arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Aligos Therapeutics, Inc.

ALGS

$4.55 ▼ -0.30 (-6.19%) at close

30 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Aligos Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $47.5M

Dividend Yield —

Revenue Growth N/M

Op. Margin None

ROIC 6.8% ↗

FCF / Share $-2.39 ↘

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-23.04M

— 0.0% —

FCF / Share Free cash flow per share

$-2.39

↓ -7.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	N/M	810.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10025%)	-72.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1001%)	-40.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-609%)	-9.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-213%)	-55.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-790%)	-9.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-223%)	15.2% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+90%)	-75.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1041%)	395.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4846%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	90.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	84.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	1.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	70.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	58.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	6.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	43.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	75.8% Excellent Excellent Year-over-year change in net income	N/M	751.4% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-194.5% Weak ↓ Weak Declining Year-over-year change in net income	-6.8% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-51.9% Weak ↓ Weak Declining Year-over-year change in net income	-27.4% Weak ↓ Weak Declining Year-over-year change in net income	3.1% Caution ↓ Caution Declining Year-over-year change in net income	5.7% Fair ↓ Fair Declining Year-over-year change in net income	35.5% Excellent ↓ Excellent Declining Year-over-year change in net income	42.0% Excellent ↑ Excellent Improving Year-over-year change in net income	43.8% Excellent ↑ Excellent Improving Year-over-year change in net income	33.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-28.7% Weak ↓ Weak Declining Year-over-year change in net income	-9.6% Weak ↑ Weak Improving Year-over-year change in net income	0.5% Caution ↑ Caution Improving Year-over-year change in net income	-43.4% Weak ↑ Weak Improving Year-over-year change in net income	-38.2% Weak ↑ Weak Improving Year-over-year change in net income	-89.3% Weak Weak Year-over-year change in net income	-137.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	10.6% Fair Fair Year-over-year change in free cash flow	—	—	—	31.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	72.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	172.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-445.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3072%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	215.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-437.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3747%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	-0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	6.8% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-85.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	71.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	16.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	19.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	22.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	24.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-2.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-14.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-72.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-582%)	-72.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-583%)	-37.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-348%)	60.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+300%)	42.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+182%)	37.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+147%)	283.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1790%)	-38.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-356%)	7.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-50%)	-58.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-489%)	-30.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-302%)	-32.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-27.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-280%)	-27.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-15.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-14.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-23.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-255%)	-20.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-15.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-17.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-218%)	-14.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-15.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	24.4% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+62%)	19.9% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+33%)	23.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+59%)	28.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+87%)	29.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+99%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-30.38M	$-29.98M	$-18.30M	$-41.95M	$-18.66M	$-73.76M	$-37.00M	$-35.33M	$-45.08M	$-24.15M	$-135.70M	$-70.43M	$-90.83M	$-78.67M	$-81.35M	$-86.44M	$-71.17M	$-104.56M	$-186.82M	$-239.73M	$-187.65M	$-200.36M	$-220.38M	$-31.82M	$-22.68M	$-25.41M	$-69.56M	$-21.13M	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.00	$0.27	—	$0.07	$0.09	$0.04	—	$0.20	$0.17	$0.11	—	$0.62	$2.48	$0.08	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.14	$-2.21	$-2.01	$-3.04	$-1.53	$5.12	$-13.10	$-3.07	$0.75	$-5.50	$0.39	$-10.25	$-10.75	$-13.25	$-12.75	$-11.00	—	—	—	$-19.50	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.39	$-2.22	—	$-2.35	—	$-2.49	—	—	—	$-3.64	—	—	—	$-13.05	—	—	—	—	—	$-15.01	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.11	$5.14	$8.67	$11.67	$16.56	$19.04	$-0.36	$0.63	$21.07	$19.76	$30.65	$31.50	$40.02	$49.34	$60.52	$71.24	$80.00	$89.52	$108.18	$127.95	$110.53	$127.94	$144.30	$-832.41	—	—	$-413.02	—	—	—
Tangible Book Value per Share (USD)	$5.11	$5.14	$8.67	$11.67	$16.56	$19.04	$-0.36	$0.63	$21.07	$19.76	$30.65	$31.50	$40.02	$49.34	$60.52	$71.24	$80.00	$89.52	$108.18	$127.95	$110.53	$127.94	$144.30	$-832.41	—	—	$-413.02	—	—	—
Basic Weighted Avg Shares (shares)	10.43M	10.40M	—	10.37M	10.35M	8.41M	—	6.27M	6.26M	6.25M	—	1.74M	1.73M	1.72M	—	1.71M	—	—	—	1.70M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$33.78M	$36.31M	$61.63M	$81.45M	$107.68M	$124.26M	$40.40M	$58.87M	$76.01M	$99.18M	$117.18M	$52.17M	$67.02M	$81.35M	$100.42M	$119.55M	$136.03M	$153.72M	$165.47M	—	$166.54M	$194.59M	$219.74M	$53.71M	—	—	$106.41M	—	—	—
Total Equity (USD)	$31.88M	$31.79M	$53.55M	$71.83M	$101.87M	$116.44M	$-28.97M	$50.10M	$67.23M	$59.80M	$92.08M	$54.82M	$69.64M	$84.75M	$103.90M	$122.01M	$136.98M	$152.89M	$184.73M	$217.01M	$168.88M	$195.22M	$220.04M	$-136.67M	$-104.57M	$-83.94M	$-64.89M	$-47.02M	$-33.37M	$-13.75M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$2.83M	$169.00K	$741.00K	$965.00K	$311.00K	$606.00K	$1.25M	$1.06M	$694.00K	$672.00K	$1.08M	$4.29M	$140.00K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$300.00K	$346.00K	$257.00K	$200.00K	$300.00K	$194.00K	$241.00K	$300.00K	$300.00K	$282.00K	$394.00K	$300.00K	$400.00K	$454.00K	$522.00K	$500.00K	$600.00K	$676.00K	$728.00K	$800.00K	$764.00K	$741.00K	$730.00K	$708.00K	$680.00K	$331.00K	$528.00K	$387.00K	—	—
Net Income, GAAP (USD)	$-23.04M	$-23.04M	$-19.88M	$43.09M	$43.09M	$43.09M	$-82.15M	$-19.26M	$5.06M	$-34.86M	$-27.89M	$-18.04M	$-18.79M	$-22.95M	$-21.89M	$-18.62M	$-19.92M	$-35.62M	$-37.71M	$-33.12M	$-29.82M	$-27.67M	$-34.42M	$-33.30M	$-20.80M	$-20.03M	$-18.18M	$-14.05M	—	—
Operating Cash Flow (USD)	$-24.95M	$-23.13M	$-21.75M	$-24.34M	—	$-20.91M	$-18.40M	—	—	$-22.75M	$-22.66M	—	—	$-22.39M	$-16.78M	—	—	$-20.43M	$-37.48M	$-25.37M	—	$-29.80M	$-19.68M	—	$-17.69M	$-20.32M	$-15.02M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 30 quarters

Aligos Therapeutics, Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ALGS with peers